The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s artificial intelligence (AI) in drug discovery market report forecasts the artificial intelligence (AI) in drug discovery market size to grow to $3.74 Billion by 2027, with a CAGR (compound annual growth rate) of more than 28%.

Learn More On The Artificial Intelligence (AI) In Drug Discovery Market Report 2023 – https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence (AI) In Drug Discovery Market Size Forecast
The global artificial intelligence (AI) in drug discovery market is expected to grow from $1.04 billion in 2022 to $1.38 billion in 2023 at a compound annual growth rate (CAGR) of 31.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global artificial intelligence (AI) in drug discovery market size is expected to grow to $3.74 billion in 2027 at a CAGR of 28.4%.

North America held the largest artificial intelligence (AI) in drug discovery market share.

Key Artificial Intelligence (AI) In Drug Discovery Market Driver ­– Rise In Demand For A Reduction In The Overall Time Taken For The Drug Discovery Process
For instance, in 2020, the British start-up Exscientia and Japan’s Sumitomo Dainippon Pharma have used artificial intelligence to produce an obsessive-compulsive disorder (OCD) medication, decreasing the development time from four years to less than one year. The reduction in overall time taken for the drug discovery process drives the artificial intelligence (AI) in drug discovery market’s growth.

Request for A Sample Of The Global Artificial Intelligence (AI) In Drug Discovery Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

Key Artificial Intelligence (AI) In Drug Discovery Market Trend – Adopting Strategic Collaborations
Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining significant popularity in the artificial intelligence in drug discovery market. For instance, in August 2022, Atomwise, a US-based artificial intelligence systems company, partnered with Sanofi. The partnership aimed at computationally identifying and investigating up to five pharmacological targets using the Atomwise AI-powered AtomNet technology. To find, create, and advance lead compounds for up to five Sanofi-exclusive targets, Atomwise received a $20 million upfront payment from Sanofi. Sanofi is a French pharmaceutical and healthcare company.

Artificial Intelligence (AI) In Drug Discovery Market Segment
1) By Technology: Deep Learning, Machine Learning
2) By Drug Type: Small Molecule, Large Molecules
3) By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Other Therapeutics
4) By End-Users: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users

Artificial Intelligence (AI) In Drug Discovery Market Major Players and Strategies
Major players in the artificial intelligence (AI) in drug discovery market are IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica and BIOAGE.

In July 2020, Curi Bio, a leading developer of human iPSC-based platforms for drug discovery, acquired Dana Solutions for an undisclosed amount. This acquisition will give Curi Bio access to Dana’s AI/ML platforms for modelling cell and tissue phenotype, automated platform for contractility analysis of beating cardiomyocyte and platform for predictive safety pharmacology. Dana Solutions is a leading AI solutions provider for the life sciences industry.

The Artificial Intelligence (AI) In Drug Discovery Global Market Report 2023 covers regional data on artificial intelligence (AI) in drug discovery market size, artificial intelligence (AI) in drug discovery market trends and drivers, opportunities, strategies, and artificial intelligence (AI) in drug discovery market competitor analysis. The countries covered in the artificial intelligence (AI) in drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Artificial intelligence (AI) is a simulation of the human intelligence in machines that are programmed to think and behave like humans. AI helps to complete the job quickly and with relatively few errors.

View More Reports Related To The Artificial Intelligence (AI) In Drug Discovery Market –
Artificial Intelligence Global Market Report 2023
Artificial Intelligence Services Global Market Report 2023
Artificial Intelligence In Healthcare Market Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: